Neurobiological and psychopharmacological basis in the therapy of bulimia and anorexia
- PMID: 8861189
- DOI: 10.1016/0278-5846(95)00306-1
Neurobiological and psychopharmacological basis in the therapy of bulimia and anorexia
Abstract
1. Eating disorders can be found in several psychiatric pathologies: schizophrenia, delusional disorder (somatic type), bipolar disorders, major depressive disorder, borderline personality disorder, generalized anxiety disorder, body dysmorphic disorder, somatization disorder and conversion disorder. 2. Although their clinical features have been defined, relatively little is known about the role of neurobiological patterns in the pathogenesis of these disorders. Several CNS neurotransmitters and neuromodulators are involved in the regulation of eating behavior in animals and have been implicated in symptoms such as depression and anxiety often observed in patients with eating disorders. The authors will review some studies on NA, DA, 5-HT, beta-endorphins, CRH, VP, OT, CCK, NPY and PYY involved in eating disorders. Furthermore, we will highlight some of the studies on drug therapy of eating disorders taking into account the effects of these agents on neurotransmitters and neuromodulators. 3. Antidepressant drugs have long been used for anorexia nervosa and bulimia, these disorders been claimed to be affective equivalent. Antidepressant agents seem to be effective in reducing the frequency of binge-eating episodes, purging behavior and depressive symptomatology. It is notable that antidepressant agents have been proved to be effective in patients with chronic bulimic symptoms, even in cases persisting for many years and in patients who had repeatedly failed courses of alternative therapeutic approaches. In all of the positive studies, antidepressant agents appeared effective even in bulimic subjects who did not display concomitant depression. 4. Few controlled studies on use of medications for anorexia nervosa have been published. Central serotonergic receptor-blocking compounds such as cyproheptadine cause marked increase in appetite and body weight. Zinc supplementation or cisapride could be a therapeutic option in addition to psychological and other approaches in anorexia nervosa. 5. There is no therapy as yet which is fully effective in alimentary disorders. Psychotropic drugs give some relief from symptoms, but they cannot cure the disorders. An integrated approach, either pharmacological or psychological, is still recommendable.
Similar articles
-
[Drug treatment of anorexia nervosa and bulimia nervosa. A review].Nervenarzt. 1993 Jan;64(1):21-35. Nervenarzt. 1993. PMID: 8437645 Review. German.
-
[Comorbidity of eating disorders and bipolar affective disorders].Psychiatr Pol. 2006 May-Jun;40(3):455-67. Psychiatr Pol. 2006. PMID: 17037812 Review. Polish.
-
[Comorbidity of bipolar and eating disorders. Epidemiologic and therapeutic aspects].Encephale. 1995 Sep-Oct;21(5):545-53. Encephale. 1995. PMID: 8529563 Review. French.
-
Neurochemical abnormalities of anorexia nervosa and bulimia nervosa.Am J Psychiatry. 1989 Aug;146(8):963-71. doi: 10.1176/ajp.146.8.963. Am J Psychiatry. 1989. PMID: 2568763 Review.
-
[Are psychotropic drugs necessary for the treatment of anorexia and bulimia nervosa?].Psychother Psychosom Med Psychol. 1997 Sep-Oct;47(9-10):332-45. Psychother Psychosom Med Psychol. 1997. PMID: 9411463 Review. German.
Cited by
-
Safety and mechanism of appetite suppression by a novel hydroxycitric acid extract (HCA-SX).Mol Cell Biochem. 2002 Sep;238(1-2):89-103. doi: 10.1023/a:1019911205672. Mol Cell Biochem. 2002. PMID: 12349913
-
Super CitriMax (HCA-SX) attenuates increases in oxidative stress, inflammation, insulin resistance, and body weight in developing obese Zucker rats.Mol Cell Biochem. 2007 Oct;304(1-2):93-9. doi: 10.1007/s11010-007-9489-3. Epub 2007 May 15. Mol Cell Biochem. 2007. PMID: 17503004
-
Hypophagia and induction of serotonin transporter gene expression in raphe nuclei of male and female rats after short-term fluoxetine treatment.J Physiol Biochem. 2013 Mar;69(1):69-74. doi: 10.1007/s13105-012-0188-5. Epub 2012 Jun 23. J Physiol Biochem. 2013. PMID: 22730080
-
Associations between the serotonin-1A receptor C(-1019)G polymorphism and disordered eating symptoms in female adolescents.J Neural Transm (Vienna). 2010 Jun;117(6):773-9. doi: 10.1007/s00702-010-0412-9. Epub 2010 May 9. J Neural Transm (Vienna). 2010. PMID: 20454985
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous